How to Buy Helius Medical Technologies Stock
Helius Medical Technologies Inc
Helius Medical Technologies, Inc. , a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma.
Helius Medical Technologies stock last closed at $0.17, up 3.75% from the previous day, and has decreased 87.85% in one year. It has underperformed other stocks in the Medical Devices industry by 0.86 percentage points. Helius Medical Technologies stock is currently +20.29% from its 52-week low of $0.14, and -93.99% from its 52-week high of $2.76.
There are currently 28.22M HSDT shares outstanding. The market cap of HSDT is $4.68M. In the last 24 hours, 118,521 HSDT shares were traded.
How to Buy Helius Medical Technologies Stock
Wondering how to invest in Helius Medical Technologies stock? Here's how.
- Decide where to buy Helius Medical Technologies stock: You need to pick a stock brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you figure out where to buy Helius Medical Technologies stock.
- Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit funds into your investment account: Choose your method of payment and add your details.
- Evaluate Helius Medical Technologies stock: The Helius Medical Technologies ticker symbol is HSDT. Is Helius Medical Technologies stock a good investment? Should you buy shares of HSDT? How do HSDT's underlying business fundamentals look? Do top analysts think Helius Medical Technologies is a good buy? Why has HSDT's stock price moved recently? (Hint: Our stock market research website can help you understand if HSDT is a good stock to buy).
- Make your HSDT buy order: Decide if you will purchase HSDT shares at the current market price or use a limit order to purchase HSDT shares at a particular price.
- Monitor your investment in HSDT: Create a watchlist to keep track of your investment in Helius Medical Technologies shares.
Step 1: Decide where to buy Helius Medical Technologies stock
You will need a brokerage account in order to access the NASDAQ market and buy HSDT shares.
Our recommended brokerage: eToro
Based on our research, eToro is the best place to buy stocks. Here's why:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world financial markets: From Tech to Industrials, New York to London — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by signing up for an account with eToro today.
Open eToro AccountStep 2: Open your brokerage account
Now that you've chosen the right brokerage, you'll need to fill out some personal info so you are able to invest in HSDT today.
How to Start a New Brokerage Account on eToro
- Click here to get started.
- Enter your personal info to start your new trading account.
- Submit your information by pressing the "Create Account" button.
Step 3: Deposit funds into your investment account
Now that you've opened your account on a good online stock trading app, you can securely and quickly fund your account:
Watch the tutorial below for more details depositing funds into your investment account.
Step 4: Evaluate Helius Medical Technologies stock
After you have chosen the best place to buy Helius Medical Technologies stock, it's critical to analyze their stock prior to investing, so you actually wrap your head around the risk and upside.
Helius Medical Technologies shares data
Fundamentals of HSDT
WallStreetZen was built to help average investors perform more accurate fundamental analysis.
You can view all of the due diligence checks on HSDT's stock page.
Is HSDT stock undervalued?
You can use many financial metrics, analyses, models, and charts to gauge HSDT's fair value.
Using relative valuations measures:
- HSDT may be undervalued based on its P/B ratio of 0.77x, relative to Medical Devices industry P/B ratio of 3.87x
You can access additional valuation research on HSDT's stock here.
HSDT Financial Overview
Passed Health Checks:
- There are more short-term assets than short-term liabilities on the HSDT balance sheet.
- HSDT has $11.34M in cash and short term investments. This is sufficient to cover its annual cash burn of $12.85M.
- Total HSDT debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the HSDT balance sheet.
Failed Health Checks:
- HSDT has a relatively high debt to equity ratio of 1.27.
- HSDT profit margin has gone up by 13.18 percentage points in the past year, but the company is still unprofitable.
- HSDT has cash burn of 12852000. It does not have enough cash and short-term investments to cover this.
Is Helius Medical Technologies stock a Buy, Hold, or Sell, according to analysts?
Out of 1 Equities analysts who monitor HSDT, the consensus analyst rating on HSDT is a Strong Buy
It's important to note that analyst forecasts are not recommendations, nor are they financial advice.
Most Recent HSDT Analyst Upgrades/Downgrades
Anthony Vendetti, a bottom 5% analyst from Maxim Group initiates coverage on HSDT with a strong buy rating and announces their HSDT price target of $1.00, on Dec 20, 2022.
You can dive deeper into what analysts are saying on the Helius Medical Technologies stock forecast page.
HSDT Trading Indicators
HSDT Growth Metrics
Last year, HSDT revenue was $708.00k. In the past 4 year, HSDT's revenue has increased by -11.52% per year. This was slower than the Medical Devices industry average of 12.46%.
Dig into HSDT's earnings and revenue performance here.
Latest Insiders Trades at HSDT
Over the past 12 months, insiders at HSDT have bought more shares than they have sold.
Dane Andreeff, President and CEO of HSDT, was the latest HSDT insider to buy. They bought $575.94 worth of HSDT shares on Dec 16, 2022.
Learn more about who owns HSDT shares here.
Does HSDT stock generate passive income?
No, Helius Medical Technologies doesn't provide an income stream by paying out dividends.
Get opinions from other traders
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Make your HSDT buy order
There are two primary order types:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are usually fine for most investors. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a given dollar amount limit, place a limit order.
Click the Open Trade button and your broker will place your order.
If you want additional help buying stocks on eToro, click the how to video below:
Step 6: Monitor your investment in HSDT
Now that you own some HSDT shares, you'll want to stay up-to-date on your new stock purchase.
Start a watchlist to get the latest updates about your HSDT stock.
HSDT Feed
How to Buy Stock in Helius Medical Technologies
To summarize, here are the 6 steps for buying Helius Medical Technologies stock:
- Decide where to buy Helius Medical Technologies stock
- Open your brokerage account
- Deposit funds into your investment account
- Evaluate Helius Medical Technologies stock
- Make your HSDT buy order
- Monitor your investment in HSDT
If you need a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to watch your new investment in Helius Medical Technologies, click below.
Trending Content
FAQ
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.